← Evidence map

ArticleFrontiers in oncology2022

Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue.

Rossella Loria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36387137